Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk
Citations Over Time
Abstract
Abstract We performed the largest genome-wide association study of PD to date, involving the analysis of 7.8M SNPs in 37.7K cases, 18.6K UK Biobank proxy-cases, and 1.4M controls. We identified 90 independent genome-wide significant signals across 78 loci, including 38 independent risk signals in 37 novel loci. These variants explained 26-36% of the heritable risk of PD. Tests of causality within a Mendelian randomization framework identified putatively causal genes for 70 risk signals. Tissue expression enrichment analysis suggested that signatures of PD loci were heavily brain-enriched, consistent with specific neuronal cell types being implicated from single cell expression data. We found significant genetic correlations with brain volumes, smoking status, and educational attainment. In sum, these data provide the most comprehensive understanding of the genetic architecture of PD to date by revealing many additional PD risk loci, providing a biological context for these risk factors, and demonstrating that a considerable genetic component of this disease remains unidentified.
Related Papers
- → The Significance of Biobanking in the Sustainability of Biomedical Research: A Review(2020)17 cited
- → Russian National Association of Biobanks and Biobanking Specialists — a tool for integrating Russian biobanks and increasing the efficiency of biomedical research Drapkina O. M.(2020)11 cited
- → The Utility of Collaborative Biobanks for Cardiovascular Research(2011)4 cited
- → Types of Biobanks(2022)3 cited
- → MGA Biobank - A Multispecialistic Project Biobank in Slovakia(2023)